Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.

@article{Weiss2006CannabidiolLI,
  title={Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.},
  author={Lawrence M. Weiss and Michael Zeira and Steven Reich and Michael Har-Noy and Raphael Mechoulam and Shimon Slavin and Ruth Gallily},
  journal={Autoimmunity},
  year={2006},
  volume={39 2},
  pages={
          143-51
        }
}
Cannabidinoids are components of the Cannabis sativa (marijuana) plant that have been shown capable of suppressing inflammation and various aspects of cell-mediated immunity. Cannabidiol (CBD), a non-psychoactive cannabidinoid has been previously shown by us to suppress cell-mediated autoimmune joint destruction in an animal model of rheumatoid arthritis. We now report that CBD treatment significantly reduces the incidence of diabetes in NOD mice from an incidence of 86% in non-treated control… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 78 CITATIONS, ESTIMATED 52% COVERAGE

Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid

VIEW 2 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol

VIEW 6 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED

Cannabidiol-induced lymphopenia does not involve NKT and NK cells.

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2007
2020

CITATION STATISTICS

  • 7 Highly Influenced Citations

  • Averaged 7 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 51 REFERENCES

Cannabinoid receptors

The cannabinoid receptors.

VIEW 1 EXCERPT

TNF-a and homocysteine levels in type 1 diabetes mellitus

  • MT Abdel Aziz, HH Fouad, GA Mohsen, M Mansour, S. Abdel Ghaffar
  • East Mediterr Health J 2001;7:679–688
  • 2001
VIEW 1 EXCERPT